SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 122.12 |
Enterprise Value ($M) | -49.42 |
Book Value ($M) | 165.05 |
Book Value / Share | 6.12 |
Price / Book | 0.74 |
NCAV ($M) | 156.97 |
NCAV / Share | 5.82 |
Price / NCAV | 0.78 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.32 |
Return on Assets (ROA) | -1.08 |
Return on Equity (ROE) | -1.53 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 13.09 |
Current Ratio | 13.09 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 183.53 |
Assets | 191.61 |
Liabilities | 26.56 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Ra Capital Management, L.p. | 7.70 | 49.78 | |
13G | Etkin Amit | 5.40 | ||
13G | Fmr Llc | 8.77 | ||
13G | BlackRock, Inc. | 5.40 | 0.00 | |
13G | Falcon Edge Capital, LP | 13.80 | ||
13G | Point72 Asset Management, L.P. | 6.30 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
134,306 | 493,590 | 27.21 | |
143,355 | 552,060 | 25.97 | |
67,556 | 333,237 | 20.27 | |
263,552 | 1,034,485 | 25.48 | |
(click for more detail) |
Similar Companies | |
---|---|
ABBV – AbbVie Inc. | ABT – Abbott Laboratories |
ADCT – ADC Therapeutics SA | ANVS – Annovis Bio, Inc. |
BHC – Bausch Health Companies Inc. |
Financial data and stock pages provided by
Fintel.io